$DD is a publicly traded company in the Defense sector. This company operates across Defense and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 6 active Congressional signals mentioning $DD, including 6 bills. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
HR5186 authorizes a DoD bioindustrial manufacturing program for defense supply chain resilience. No direct appropriation — this is a pipeline-creating authorization that positions synthetic biology ($DNA), agricultural processing ($ADM), and specialty materials ($DD) firms for future contract awards. The bill is in early legislative stage (referred to committee), but the companion NDAA FY2026 (S1071) has already become law, creating a clear legislative pathway for defense biomanufacturing funding in subsequent appropriations.
HR 6616 (Clean Water Justice Act) proposes a 400% increase in maximum criminal fines for Clean Water Act violations but remains in early legislative stages (referred to subcommittee). The bill carries no direct spending or revenue, and current market prices for affected tickers show no correlation to this procedural event. Immediate market impact is negligible.
HR 6668 mandates EPA PFAS discharge limits within 3 years with zero federal compliance funding, imposing costs on manufacturers $MMM, $DD, $DOW and water utility $AWK, while benefiting treatment provider $XYL. At $134.88, $AWK trades near the middle of its 52-week range with a flat 30-day trend, reflecting the market's anticipation of utility capex pressure. The bill's early stage suggests limited immediate catalyst, but the regulatory trajectory is clear regardless of this specific legislation's fate.
HR7181 (Replacement Parts Availability Act) is an early-stage, bipartisan bill that clarifies TSCA exemptions for chemical substances used in replacement parts. It offers mild regulatory relief for chemical manufacturers supplying the aftermarket and MRO sectors, but has no authorization or appropriation of funds. The bill faces a long legislative path with uncertain passage timelines.
HR161 (New Source Review Permitting Improvement Act) reported out of House Energy & Commerce Committee on April 28, 2026. Refiners ($MPC, $PSX) and chemical companies ($LYB, $DOW) show strong 7-day gains of +9.37% and +8.75% respectively, reflecting market pricing of regulatory relief. The bill redefines NSR 'modification' to require a 10-year peak-hourly baseline and exempts reliability/safety projects, directly lowering compliance costs for heavy industry.
HR1267 is an early-stage bill exempting water utilities from CERCLA liability for PFAS, shifting cleanup costs to chemical manufacturers. The bill is in committee with 26 cosponsors and no floor action. Water utility stocks ($WTRG at $39.49, $CWT at $45.38) show mixed near-term trends; no market reaction to this bill is observable. Chemical manufacturers $DD at $44.62 and $MMM at $143.87 face potential increased liability exposure but remain near their 52-week ranges.